Dow Jones

38,834.86

0.15%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Bristol Myers Squibb Company (PK) (BMYMP)
Bristol Myers Squibb Company (PK) (BMYMP) Noticias

BMYMP

Bristol Myers Squibb (PK) (BMYMP)

Bristol Myers Squibb Company (PK)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BMYMP

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/06/2024	15:23	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
16/02/2024	15:34	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
16/02/2024	10:36	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
13/02/2024	10:54	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
13/02/2024	07:00	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
05/02/2024	18:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/01/2024	16:48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/12/2023	15:13	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
26/10/2023	11:33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/08/2023	14:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
08/06/2023	14:44	Edgar (US Regulatory)	Annual Report of Employee Stock Plans (11-k)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
06/06/2023	18:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2023	15:49	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/05/2023	18:35	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/05/2023	12:45	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
26/04/2023	15:39	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
23/03/2023	15:44	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
14/02/2023	15:41	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
07/02/2023	13:12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
27/07/2022	10:03	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
05/04/2022	15:53	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
15/02/2022	16:28	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
15/02/2022	08:13	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
21/01/2022	16:41	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
13/12/2021	15:32	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2021	16:03	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2021	15:56	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
25/03/2021	18:32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/01/2021	08:34	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
12/11/2020	15:22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)